GW28-e1184 Comparison of clinical outcomes between patients with Stanford B aortic dissection treated with endovascular aortic repair of different genders in a single center

Objective Thoracic endovascular aortic repair (TEVAR) is considered the mini-invasive treatment of choice for patients with Stanford type B aortic dissection (TBAD). This study aimed to investigate the clinical outcomes and quality of life (QoL) in patients with acute and subacute TBAD after TEVAR. Methods From January 2014 until July 2016, 22 acute patients (Group A) and 18 subacute patients received TEVAR (Group B), and 13 patients were managed non-operatively (Group C). The Medical Outcomes Study Short Form-36 was used to assess QoL preoperatively and after TEVAR. Operative techniques and complications were retrospectively analyzed. Results The role emotion, vitality, and mental health domains scored well preoperatively. Except for role emotion, vitality, and mental health, the remaining domains significantly improved after TEVAR. There was no significant difference in QoL metrics between Groups A and B. In Group C, bodily pain and social functioning domains were improved, and role emotion was decreased, with no improvement in the remaining domains. The 3-year survival rates were 95.5%, 100%, and 85.7% for Groups A, B, and C, respectively. Conclusions TEVAR may be safe and effective in patients with acute and subacute TBAD with similar and favorable clinical and QoL metrics.

Download Full-text

Effects of circulating levels of Th17 cells on the outcomes of acute Stanford B aortic dissection patients after thoracic endovascular aortic repair

Medicine ◽

10.1097/md.0000000000018241 ◽

2019 ◽

Vol 98 (50) ◽

pp. e18241 ◽

Cited By ~ 2

Author(s):

Hongtao Liu ◽

Ting Xiao ◽

Le Zhang ◽

Ying Huang ◽

Ying Shi ◽

...

Keyword(s):

Aortic Dissection ◽

Th17 Cells ◽

Thoracic Endovascular Aortic Repair ◽

Endovascular Aortic Repair ◽

Aortic Repair ◽

Circulating Levels ◽

Stanford B

Download Full-text

Aortic-related Readmission after Thoracic Endovascular Aortic Repair for Type B Aortic Dissection Patients: A Single-center Retrospective Study

Annals of Vascular Surgery ◽

10.1016/j.avsg.2021.10.072 ◽

2021 ◽

Author(s):

Yuanqing Kan ◽

Lihong Huang ◽

Zhenyu Shi ◽

Daqiao Guo ◽

Yi Si ◽

...

Keyword(s):

Retrospective Study ◽

Aortic Dissection ◽

Thoracic Endovascular Aortic Repair ◽

Endovascular Aortic Repair ◽

Type B ◽

Single Center ◽

Type B Aortic Dissection ◽

Aortic Repair

Download Full-text

Preoperative proteinuria and clinical outcomes in type B aortic dissection after thoracic endovascular aortic repair

Clinical Chemistry and Laboratory Medicine (CCLM) ◽

10.1515/cclm-2018-0765 ◽

2019 ◽

Vol 57 (5) ◽

pp. 752-758

Author(s):

Hongwei Yang ◽

Jianwei Zhou ◽

Keli Huang ◽

Tao Yu ◽

Zuhui Wang ◽

...

Keyword(s):

Aortic Dissection ◽

Clinical Outcomes ◽

Multivariate Logistic Regression Analysis ◽

Thoracic Endovascular Aortic Repair ◽

Endovascular Aortic Repair ◽

Type B ◽

Urine Dipstick ◽

Aortic Repair

Abstract Background Proteinuria is a marker of poor outcomes in several diseases; however, few studies have been conducted to explore the prognostic value of proteinuria, assessed by urine dipstick test, for clinical outcomes in patients with type B acute aortic dissection (TBAD) undergoing thoracic endovascular aortic repair (TEVAR). Methods Consecutive patients with TBAD undergoing TEVAR were enrolled from January 2010 to July 2015. Proteinuria was defined as trace or higher, according to the results of urine dipstick testing. Associations among proteinuria and adverse events were evaluated. Results In total, 671 patients with a mean age of 44±15 years were included in the analysis. Proteinuria was detected in 281 patients (41.9%) before TEVAR. Multivariate logistic regression analysis showed that C-reactive protein and impaired renal function were independent predictors for proteinuria. During hospitalization, 21 patients died. In-hospital mortality was higher in patients with proteinuria (1.5% vs. 5.3%, p=0.005). After a median 3.4 years follow up, the post-TEVAR death rate was 10.4% (85 patients were lost to follow-up). The long-term cumulative mortality was significantly higher in patients with proteinuria (17.2% vs. 8.2%, log-rank=11.36, p=0.001). Multivariate Cox survival modeling indicated that proteinuria was significantly associated with long-term death, after adjustment for potential confounding risk factors (HR=1.92, p=0.012). Conclusions Pre-TEVAR proteinuria was identified as a prognostic marker in patients with TBAD and has potential for application as a convenient and simple risk assessment method before TEVAR.

Download Full-text